People with endometriosis may have seen stories of pain improving on Ozempic, Wegovy or Mounjaro. Here's what the evidence actually shows, who might reasonably consider a GLP-1 medicine, and what to know about safety, contraception and cost in New Zealand.
Most HPV clears by itself within a year or two. For about one in ten people it doesn’t — and the advice is usually to come back in 12 months. Here is what genuinely helps in the meantime, and an honest look at the evidence for the supplement AHCC.
New research in The BMJ and JAMA Neurology links long-term Depo-Provera use to a small increase in meningioma risk. This article explains the findings, puts the risk in context, and explores what it means for those using Depo-Provera for contraception or endometriosis management.
Heavy menstrual bleeding is a common problem that can affect work, social life, and overall wellbeing. Many women are told that the main treatments involve hormones — such as the pill, progesterone tablets, or the hormonal IUD. While these are very effective, they don’t suit everyone.
One of the most significant yet often unspoken issues I encounter is period poverty. In Aotearoa, a lack of access to affordable period products is not just a financial issue; it’s a public health crisis that affects education, dignity, and well-being.
For the first time in nine years, there’s a new medical treatment available in New Zealand. Ryeqo (relugolix, estradiol, norethisterone acetate) is now registered for adults of reproductive age who have tried other medical or surgical treatments for their endometriosis.
